Asia Pacific Scales Daptomycin Manufacturing as Resistance Rises
The Daptomycin Market was valued at USD 4.09 billion in 2025 and is projected to reach nearly USD 5.29 billion by 2032, registering a compound annual growth rate (CAGR) of 3.73% during the 2026–2032 forecast period. Rising rates of multidrug-resistant Gram-positive infections—including methicillin-resistant Staphylococcus aureus (MRSA)—and expanding clinical use in...
0 Commentarios 0 Acciones 24 Views 0 Vista previa
SocioMint https://sociomint.com